Cargando…
Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791265/ https://www.ncbi.nlm.nih.gov/pubmed/33437809 http://dx.doi.org/10.21037/atm-20-3702 |
| _version_ | 1783633575221919744 |
|---|---|
| author | Doggrell, Sheila A. |
| author_facet | Doggrell, Sheila A. |
| author_sort | Doggrell, Sheila A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7791265 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77912652021-01-11 Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists Doggrell, Sheila A. Ann Transl Med Editorial Commentary AME Publishing Company 2020-12 /pmc/articles/PMC7791265/ /pubmed/33437809 http://dx.doi.org/10.21037/atm-20-3702 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Doggrell, Sheila A. Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists |
| title | Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists |
| title_full | Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists |
| title_fullStr | Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists |
| title_full_unstemmed | Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists |
| title_short | Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists |
| title_sort | exenatide at mealtimes in type 1 diabetes—no mag1c with exenatide, or with other glucagon-like peptide-1 receptor agonists |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791265/ https://www.ncbi.nlm.nih.gov/pubmed/33437809 http://dx.doi.org/10.21037/atm-20-3702 |
| work_keys_str_mv | AT doggrellsheilaa exenatideatmealtimesintype1diabetesnomag1cwithexenatideorwithotherglucagonlikepeptide1receptoragonists |